The Next Generation Biotech Media
On January 18th, Munich, Germany-based gene therapy company, ViGeneron announced a research collaboration with Daiichi Sankyo on a novel therapeutic protein to address an undisclosed target in a highly prevalent …
Read More
On January 15th, Pfizer announced FDA approval for its tyrosine kinase inhibitor, Xalkori, which can be used in pediatric patients one year of age and older and young adults with …
Read More
On January 15th, Thermo Fisher Scientific announced the acquisition of Henogen, Novasep’s viral-vector manufacturing division in Belgium, for about $879 million in cash. It will be part of Thermo Fisher’s …
Read More
As SARS-CoV-2, the causative agent for COVID-19, continues to cause rampant destruction on human lives globally, biopharma companies are stepping up their game to provide some relief. The latest one …
Read More
Cancer therapy without a doubt will be one of the most trending topics in 2021. As several contenders push their way into the field, on January 13, Japanese biopharma, Takeda …
Read More
In recent times, several big pharma have collaborated with small companies in the immuno-oncology field. Last September, Pfizer made a $200 million investment to collaborate with CStone Pharmaceuticals. Now Novartis …
Read More
On January 4th, China-based biotech Gracell Biotechnologies (Gracell) revealed details of the IPO. Gracell is offering 8.8 million American depositary shares (ADS) with 16 to 18 apiece, which will result …
Read More
The Philippines government has signed a second vaccine deal to procure 30 million doses of Covovax, the COVID-19 vaccine developed by Novavax. The candidate is developed by the Serum Institute …
Read More
After delivering a stellar performance last year, Alnylam, a leading RNAi therapeutics company, is now eyeing a position in the top 5 biotech companies in market cap by 2025. At …
Read More
On January 7th, Sarepta Therapeutics reported the first part results of its Phase 2 clinical trial that evaluated the gene transfer therapy, SRP-9001. Although the delivery of the therapy increased …
Read More